Eupraxia Pharmaceuticals Inc
(EPRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 88,959 | 19,766 | 27,455 | 33,101 | 8,662 |
| Receivables | 140 | 135 | 239 | 229 | 106 |
| TOTAL | $91,400 | $22,830 | $28,606 | $34,437 | $9,890 |
| Non-Current Assets | |||||
| PPE Net | 683 | 656 | 497 | 358 | 370 |
| Other Non-Current Assets | 266 | 111 | 130 | 148 | 105 |
| TOTAL | $949 | $766 | $627 | $506 | $475 |
| Total Assets | $92,349 | $23,596 | $29,233 | $34,942 | $10,365 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,735 | 2,583 | 2,147 | 3,032 | 2,294 |
| TOTAL | $3,811 | $2,618 | $2,200 | $3,103 | $2,373 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8 | 7 | 5 | 23 | 48 |
| TOTAL | $95 | $N/A | $N/A | $N/A | $14 |
| Total Liabilities | $3,906 | $2,618 | $2,200 | $3,103 | $2,387 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | N/A | 35,642 | N/A |
| Common Shares | 191,017 | 117,117 | 116,840 | 116,360 | 116,318 |
| Retained earnings | -152,869 | -146,507 | -137,766 | -131,004 | -123,495 |
| Other shareholders' equity | -4,881 | -4,365 | -5,693 | -5,726 | -4,337 |
| TOTAL | $88,444 | $20,978 | $27,033 | $31,839 | $7,978 |
| Total Liabilities And Equity | $92,349 | $23,596 | $29,233 | $34,942 | $10,365 |